This clinical trial is focused on studying the management of risk factors related to heart disease, specifically looking at how well certain medications can control blood pressure and cholesterol levels. The study involves a treatment called the Trinomia polypill, which is a combination of three medications: ramipril, acetylsalicylic acid (commonly known as aspirin), and atorvastatin calcium trihydrate. These medications are used to help manage blood pressure, prevent blood clots, and lower cholesterol, respectively. The trial will also involve the use of these medications separately to compare their effectiveness.
The purpose of the study is to analyze the level of systolic blood pressure (the top number in a blood pressure reading) and LDL cholesterol (often referred to as “bad” cholesterol) in the same patient during two different periods. One period involves treatment with the Trinomia polypill for three months, and the other involves treatment with the individual components for three months. This approach helps to understand how the combination pill compares to taking the medications separately.
Participants in the study will take the medications orally, as they are available in capsule or tablet form. The study will last for a total of six months, with patients switching between the polypill and the separate medications. The trial aims to provide insights into the best way to manage heart disease risk factors, potentially improving treatment strategies for patients with ischemic heart disease, a condition where the heart’s blood supply is reduced due to narrowed arteries.
Spain 
